Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis

OBJECTIVES To examine differences in gene expression levels between renal cell carcinoma (RCC) tissue and ‘normal’ appearing renal tissue using a commercially available DNA macroarray. MATERIALS AND METHODS Tissue was obtained from 47 consecutive radical nephrectomies, 29 of which were eligible. DNA...

Full description

Saved in:
Bibliographic Details
Published inBJU international Vol. 98; no. 1; pp. 205 - 216
Main Authors LOVISOLO, JON A.J., CASATI, BARBARA, CLERICI, LIBERO, MARAFANTE, ERMINIO, BONO, ALDO V., CELATO, NICOLA, SALVADORE, MAURIZIO
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.07.2006
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
Abstract OBJECTIVES To examine differences in gene expression levels between renal cell carcinoma (RCC) tissue and ‘normal’ appearing renal tissue using a commercially available DNA macroarray. MATERIALS AND METHODS Tissue was obtained from 47 consecutive radical nephrectomies, 29 of which were eligible. DNA macroarrays were analysed on the tumour and normal‐appearing control tissue to measure the expression of 1185 cancer‐related genes. The group of samples was also stratified according to the presence or absence of granular cells and according to tumour grade. Quantitative real‐time polymerase‐chain reaction (PCR) was also performed on seven key genes present on the macroarray. RESULTS In all, 444 genes were over‐expressed and 33 genes were under‐expressed. Using selection criteria reduced the list to nine that were significantly over‐expressed and 23 that were under‐expressed. These significant genes belonged to the families of oncogenes, growth factors, interleukins, receptors, immune system components, cytoskeleton, matrix proteins and intracellular modulators, or they coded for proteins involved in DNA transcription and RNA translation, DNA repair, protein turnover, and metabolism of carbohydrates and lipids. There were differences in gene expression according to the presence or absence of granular cells and according to tumour grade. Using quantitative real‐time PCR there was over‐expression of epidermal growth factor receptor, c‐myc, transforming growth factor‐α, vascular endothelial growth factor and vimentin, and under‐expression of TYRO3 protein tyrosine kinase. The von Hippel–Lindau gene was under‐expressed but not significantly. CONCLUSIONS A procedure for collecting and storing fresh renal tissue and subsequent gene expression profiling of RCC and normal renal tissue was established. A commercially available DNA macroarray coupled with the significance analysis of macroarrays allowed the identification of sets of differentially expressed cancer‐related genes that were characteristic of RCC, compared with apparently normal renal tissue, and which distinguished among subgroups divided according to tumour grade and histological subtype. Quantitative PCR is important to validate the results of macroarray experiments.
AbstractList OBJECTIVES To examine differences in gene expression levels between renal cell carcinoma (RCC) tissue and ‘normal’ appearing renal tissue using a commercially available DNA macroarray. MATERIALS AND METHODS Tissue was obtained from 47 consecutive radical nephrectomies, 29 of which were eligible. DNA macroarrays were analysed on the tumour and normal‐appearing control tissue to measure the expression of 1185 cancer‐related genes. The group of samples was also stratified according to the presence or absence of granular cells and according to tumour grade. Quantitative real‐time polymerase‐chain reaction (PCR) was also performed on seven key genes present on the macroarray. RESULTS In all, 444 genes were over‐expressed and 33 genes were under‐expressed. Using selection criteria reduced the list to nine that were significantly over‐expressed and 23 that were under‐expressed. These significant genes belonged to the families of oncogenes, growth factors, interleukins, receptors, immune system components, cytoskeleton, matrix proteins and intracellular modulators, or they coded for proteins involved in DNA transcription and RNA translation, DNA repair, protein turnover, and metabolism of carbohydrates and lipids. There were differences in gene expression according to the presence or absence of granular cells and according to tumour grade. Using quantitative real‐time PCR there was over‐expression of epidermal growth factor receptor, c‐ myc , transforming growth factor‐α, vascular endothelial growth factor and vimentin, and under‐expression of TYRO3 protein tyrosine kinase. The von Hippel–Lindau gene was under‐expressed but not significantly. CONCLUSIONS A procedure for collecting and storing fresh renal tissue and subsequent gene expression profiling of RCC and normal renal tissue was established. A commercially available DNA macroarray coupled with the significance analysis of macroarrays allowed the identification of sets of differentially expressed cancer‐related genes that were characteristic of RCC, compared with apparently normal renal tissue, and which distinguished among subgroups divided according to tumour grade and histological subtype. Quantitative PCR is important to validate the results of macroarray experiments.
To examine differences in gene expression levels between renal cell carcinoma (RCC) tissue and 'normal' appearing renal tissue using a commercially available DNA macroarray. Tissue was obtained from 47 consecutive radical nephrectomies, 29 of which were eligible. DNA macroarrays were analysed on the tumour and normal-appearing control tissue to measure the expression of 1185 cancer-related genes. The group of samples was also stratified according to the presence or absence of granular cells and according to tumour grade. Quantitative real-time polymerase-chain reaction (PCR) was also performed on seven key genes present on the macroarray. In all, 444 genes were over-expressed and 33 genes were under-expressed. Using selection criteria reduced the list to nine that were significantly over-expressed and 23 that were under-expressed. These significant genes belonged to the families of oncogenes, growth factors, interleukins, receptors, immune system components, cytoskeleton, matrix proteins and intracellular modulators, or they coded for proteins involved in DNA transcription and RNA translation, DNA repair, protein turnover, and metabolism of carbohydrates and lipids. There were differences in gene expression according to the presence or absence of granular cells and according to tumour grade. Using quantitative real-time PCR there was over-expression of epidermal growth factor receptor, c-myc, transforming growth factor-alpha, vascular endothelial growth factor and vimentin, and under-expression of TYRO3 protein tyrosine kinase. The von Hippel-Lindau gene was under-expressed but not significantly. A procedure for collecting and storing fresh renal tissue and subsequent gene expression profiling of RCC and normal renal tissue was established. A commercially available DNA macroarray coupled with the significance analysis of macroarrays allowed the identification of sets of differentially expressed cancer-related genes that were characteristic of RCC, compared with apparently normal renal tissue, and which distinguished among subgroups divided according to tumour grade and histological subtype. Quantitative PCR is important to validate the results of macroarray experiments.
OBJECTIVETo examine differences in gene expression levels between renal cell carcinoma (RCC) tissue and 'normal' appearing renal tissue using a commercially available DNA macroarray.MATERIALS AND METHODSTissue was obtained from 47 consecutive radical nephrectomies, 29 of which were eligible. DNA macroarrays were analysed on the tumour and normal-appearing control tissue to measure the expression of 1185 cancer-related genes. The group of samples was also stratified according to the presence or absence of granular cells and according to tumour grade. Quantitative real-time polymerase-chain reaction (PCR) was also performed on seven key genes present on the macroarray.RESULTSIn all, 444 genes were over-expressed and 33 genes were under-expressed. Using selection criteria reduced the list to nine that were significantly over-expressed and 23 that were under-expressed. These significant genes belonged to the families of oncogenes, growth factors, interleukins, receptors, immune system components, cytoskeleton, matrix proteins and intracellular modulators, or they coded for proteins involved in DNA transcription and RNA translation, DNA repair, protein turnover, and metabolism of carbohydrates and lipids. There were differences in gene expression according to the presence or absence of granular cells and according to tumour grade. Using quantitative real-time PCR there was over-expression of epidermal growth factor receptor, c-myc, transforming growth factor-alpha, vascular endothelial growth factor and vimentin, and under-expression of TYRO3 protein tyrosine kinase. The von Hippel-Lindau gene was under-expressed but not significantly.CONCLUSIONSA procedure for collecting and storing fresh renal tissue and subsequent gene expression profiling of RCC and normal renal tissue was established. A commercially available DNA macroarray coupled with the significance analysis of macroarrays allowed the identification of sets of differentially expressed cancer-related genes that were characteristic of RCC, compared with apparently normal renal tissue, and which distinguished among subgroups divided according to tumour grade and histological subtype. Quantitative PCR is important to validate the results of macroarray experiments.
OBJECTIVES: To examine differences in gene expression levels between renal cell carcinoma (RCC) tissue and 'normal' appearing renal tissue using a commercially available DNA macroarray. MATERIALS AND METHODS: Tissue was obtained from 47 consecutive radical nephrectomies, 29 of which were eligible. DNA macroarrays were analysed on the tumour and normal-appearing control tissue to measure the expression of 1185 cancer-related genes. The group of samples was also stratified according to the presence or absence of granular cells and according to tumour grade. Quantitative real-time polymerase-chain reaction (PCR) was also performed on seven key genes present on the macroarray. RESULTS: In all, 444 genes were over-expressed and 33 genes were under-expressed. Using selection criteria reduced the list to nine that were significantly over-expressed and 23 that were under-expressed. These significant genes belonged to the families of oncogenes, growth factors, interleukins, receptors, immune system components, cytoskeleton, matrix proteins and intracellular modulators, or they coded for proteins involved in DNA transcription and RNA translation, DNA repair, protein turnover, and metabolism of carbohydrates and lipids. There were differences in gene expression according to the presence or absence of granular cells and according to tumour grade. Using quantitative real-time PCR there was over-expression of epidermal growth factor receptor, c-myc, transforming growth factor- alpha , vascular endothelial growth factor and vimentin, and under-expression of TYRO3 protein tyrosine kinase. The von Hippel-Lindau gene was under-expressed but not significantly. CONCLUSIONS: A procedure for collecting and storing fresh renal tissue and subsequent gene expression profiling of RCC and normal renal tissue was established. A commercially available DNA macroarray coupled with the significance analysis of macroarrays allowed the identification of sets of differentially expressed cancer-related genes that were characteristic of RCC, compared with apparently normal renal tissue, and which distinguished among subgroups divided according to tumour grade and histological subtype. Quantitative PCR is important to validate the results of macroarray experiments.
OBJECTIVES To examine differences in gene expression levels between renal cell carcinoma (RCC) tissue and ‘normal’ appearing renal tissue using a commercially available DNA macroarray. MATERIALS AND METHODS Tissue was obtained from 47 consecutive radical nephrectomies, 29 of which were eligible. DNA macroarrays were analysed on the tumour and normal‐appearing control tissue to measure the expression of 1185 cancer‐related genes. The group of samples was also stratified according to the presence or absence of granular cells and according to tumour grade. Quantitative real‐time polymerase‐chain reaction (PCR) was also performed on seven key genes present on the macroarray. RESULTS In all, 444 genes were over‐expressed and 33 genes were under‐expressed. Using selection criteria reduced the list to nine that were significantly over‐expressed and 23 that were under‐expressed. These significant genes belonged to the families of oncogenes, growth factors, interleukins, receptors, immune system components, cytoskeleton, matrix proteins and intracellular modulators, or they coded for proteins involved in DNA transcription and RNA translation, DNA repair, protein turnover, and metabolism of carbohydrates and lipids. There were differences in gene expression according to the presence or absence of granular cells and according to tumour grade. Using quantitative real‐time PCR there was over‐expression of epidermal growth factor receptor, c‐myc, transforming growth factor‐α, vascular endothelial growth factor and vimentin, and under‐expression of TYRO3 protein tyrosine kinase. The von Hippel–Lindau gene was under‐expressed but not significantly. CONCLUSIONS A procedure for collecting and storing fresh renal tissue and subsequent gene expression profiling of RCC and normal renal tissue was established. A commercially available DNA macroarray coupled with the significance analysis of macroarrays allowed the identification of sets of differentially expressed cancer‐related genes that were characteristic of RCC, compared with apparently normal renal tissue, and which distinguished among subgroups divided according to tumour grade and histological subtype. Quantitative PCR is important to validate the results of macroarray experiments.
Author BONO, ALDO V.
MARAFANTE, ERMINIO
CLERICI, LIBERO
CELATO, NICOLA
CASATI, BARBARA
SALVADORE, MAURIZIO
LOVISOLO, JON A.J.
Author_xml – sequence: 1
  givenname: JON A.J.
  surname: LOVISOLO
  fullname: LOVISOLO, JON A.J.
– sequence: 2
  givenname: BARBARA
  surname: CASATI
  fullname: CASATI, BARBARA
– sequence: 3
  givenname: LIBERO
  surname: CLERICI
  fullname: CLERICI, LIBERO
– sequence: 4
  givenname: ERMINIO
  surname: MARAFANTE
  fullname: MARAFANTE, ERMINIO
– sequence: 5
  givenname: ALDO V.
  surname: BONO
  fullname: BONO, ALDO V.
– sequence: 6
  givenname: NICOLA
  surname: CELATO
  fullname: CELATO, NICOLA
– sequence: 7
  givenname: MAURIZIO
  surname: SALVADORE
  fullname: SALVADORE, MAURIZIO
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17878303$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16831170$$D View this record in MEDLINE/PubMed
BookMark eNqNkEtPAyEUhYmp0Vb9C4aN7jryKgwmLmp9p9GNJu4IZRhDM8NUsLHz72VstUtlARf4zuVwBqDnG28BgBhlOI2zeYYZZ0OG0WtGEOIZ4gTJbLUD-r8XvZ8aSb4PBjHOEUoHfLQH9jHPKcYC9cH01noL7WoRbIyu8XARmtJVzr_BpoTBel1BY6s06WCcb2p9DjW8ehzDWpvQ6BB0C3Wi2ujiIdgtdRXt0WY9AC8318-Tu-H06fZ-Mp4ODSO5HMrCzhCVnPIRp6YYYZlLyliBDZkxUwhMtCBapg0upCgREsyaEUkKUhbMEHoATtd9k9n3pY0fqnaxc6m9bZZR8ZwTibj4E0zZCSElTWC-BtOfYgy2VIvgah1ahZHqIldz1aWpumQ7GVffkatVkh5v3ljOaltshZuME3CyAXQ0uiqD9sbFLSdykVPUebhYc5-usu2_DajLh5euol8bhJzW
CitedBy_id crossref_primary_10_1002_jcb_23207
crossref_primary_10_1074_mcp_M600310_MCP200
crossref_primary_10_3233_CBM_181558
crossref_primary_10_2353_ajpath_2010_091218
crossref_primary_10_1007_s13277_013_1344_4
crossref_primary_10_1111_j_1440_1827_2007_02156_x
Cites_doi 10.1101/gr.184501
10.1073/pnas.82.20.6980
10.1016/S0022-5347(17)41730-7
10.1073/pnas.241500798
10.1016/S0140-6736(02)08270-3
10.1038/sj.onc.1207979
10.1016/S0002-9440(10)63887-4
10.1056/NEJMoa012914
10.1073/pnas.091062498
10.1038/bjc.1995.75
10.1073/pnas.171209998
10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G
10.1186/1471-2407-3-31
10.1016/S0002-9440(10)64120-X
10.1007/s001099900022
10.1016/S0002-9440(10)65349-7
10.1158/0008-5472.CAN-03-2361
10.1038/sj.onc.1206869
10.1038/35000501
10.1038/ng0594-85
10.1006/bbrc.1999.0465
10.1073/pnas.1131754100
10.1111/j.1523-1755.2005.00738.x
ContentType Journal Article
Copyright 2006 INIST-CNRS
Copyright_xml – notice: 2006 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TM
8FD
FR3
P64
RC3
7X8
DOI 10.1111/j.1464-410X.2006.06209.x
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Nucleic Acids Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Engineering Research Database
Technology Research Database
Nucleic Acids Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
Genetics Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1464-410X
EndPage 216
ExternalDocumentID 10_1111_j_1464_410X_2006_06209_x
16831170
17878303
BJU6209
Genre article
Journal Article
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZGI
ZXP
~IA
~WT
08R
1OB
AAPBV
AAUGY
AAVGM
ABHUG
ABPTK
ABWRO
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
IQODW
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TM
8FD
FR3
P64
RC3
7X8
ID FETCH-LOGICAL-c4289-9deb039636563cd51989344d1c2b4cd712a72a92b41d97f0074ec523962fd4c23
IEDL.DBID DR2
ISSN 1464-4096
IngestDate Fri Aug 16 03:55:22 EDT 2024
Fri Aug 16 04:36:22 EDT 2024
Fri Aug 23 01:07:55 EDT 2024
Sat Sep 28 07:41:50 EDT 2024
Sun Oct 22 16:05:09 EDT 2023
Sat Aug 24 00:46:44 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Kidney disease
Human
Nephrology
Urinary system disease
Carcinoma
macroarray
Malignant tumor
Gene expression
Real time
quantitative real-time PCR
Urology
Gene expression profile
Polymerase chain reaction
renal cell carcinoma
Cancerology
Kidney cancer
Genetics
Grawitz tumor
genomics
Molecular biology
DNA macroarray
Quantitative analysis
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4289-9deb039636563cd51989344d1c2b4cd712a72a92b41d97f0074ec523962fd4c23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 16831170
PQID 20077993
PQPubID 23462
PageCount 12
ParticipantIDs proquest_miscellaneous_68629067
proquest_miscellaneous_20077993
crossref_primary_10_1111_j_1464_410X_2006_06209_x
pubmed_primary_16831170
pascalfrancis_primary_17878303
wiley_primary_10_1111_j_1464_410X_2006_06209_x_BJU6209
PublicationCentury 2000
PublicationDate July 2006
PublicationDateYYYYMMDD 2006-07-01
PublicationDate_xml – month: 07
  year: 2006
  text: July 2006
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
PublicationTitle BJU international
PublicationTitleAlternate BJU Int
PublicationYear 2006
Publisher Blackwell Publishing Ltd
Blackwell
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell
References 2004; 64
1995; 71
2004; 23
2002; 359
1950
1985; 82
1988; 140
2002
1995; 1
1996; 13
2005; 68
1997; 183
2000; 403
1988; 48
1995; 22
2003; 9
2003; 162
2003; 3
1999; 154
2002; 346
1999; 77
1999; 257
2001; 11
2003; 100
2001; 158
2003; 22
1994; 7
2001; 98
e_1_2_7_5_2
e_1_2_7_4_2
e_1_2_7_3_2
e_1_2_7_2_2
e_1_2_7_9_2
e_1_2_7_8_2
e_1_2_7_7_2
e_1_2_7_6_2
e_1_2_7_19_2
e_1_2_7_18_2
e_1_2_7_17_2
e_1_2_7_16_2
e_1_2_7_13_2
e_1_2_7_11_2
e_1_2_7_10_2
e_1_2_7_28_2
e_1_2_7_29_2
Lager DJ (e_1_2_7_20_2) 1994; 7
Bliss CI. (e_1_2_7_15_2) 1950
Yao M (e_1_2_7_23_2) 1988; 48
e_1_2_7_25_2
e_1_2_7_24_2
e_1_2_7_30_2
e_1_2_7_31_2
e_1_2_7_22_2
e_1_2_7_32_2
Yagoda A (e_1_2_7_12_2) 1995; 22
Amundadottir LT (e_1_2_7_26_2) 1996; 13
American Joint Committee on Cancer (e_1_2_7_14_2) 2002
Uhlman DL (e_1_2_7_21_2) 1995; 1
Pantuck AJ (e_1_2_7_27_2) 2003; 9
References_xml – volume: 158
  start-page: 1639
  year: 2001
  end-page: 51
  article-title: Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers
  publication-title: Am J Pathol
– start-page: 449
  year: 1950
  end-page: 451
– volume: 48
  start-page: 6753
  year: 1988
  end-page: 7
  article-title: Enhanced expression of c‐myc and epidermal growth factor receptor (C‐erbB‐1) genes in primary human renal cancer
  publication-title: Cancer Res
– volume: 403
  start-page: 503
  year: 2000
  end-page: 11
  article-title: Distinct types of diffuse large B‐cell lymphoma identified by gene expression profiling
  publication-title: Nature
– volume: 98
  start-page: 13784
  year: 2001
  end-page: 9
  article-title: Diversity of gene expression in adenocarcinoma of the lung
  publication-title: Proc Natl Acad Sci USA
– volume: 23
  start-page: 8171
  year: 2004
  end-page: 83
  article-title: Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2
  publication-title: Oncogene
– volume: 257
  start-page: 855
  year: 1999
  end-page: 9
  article-title: Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique
  publication-title: Biochem Biophys Res Commun
– volume: 3
  start-page: 31
  year: 2003
  article-title: Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of macroarray data
  publication-title: BMC Cancer
– volume: 22
  start-page: 6810
  year: 2003
  end-page: 8
  article-title: Molecular subclassification of kidney tumors and the discovery of new diagnostic markers
  publication-title: Oncogene
– volume: 359
  start-page: 1301
  year: 2002
  end-page: 7
  article-title: Molecular characterisation of soft tissue tumours: a gene expression study
  publication-title: Lancet
– volume: 100
  start-page: 6958
  year: 2003
  end-page: 63
  article-title: Predicting survival in patients with metastatic kidney cancer by gene‐expression profiling in the primary tumor
  publication-title: Proc Natl Acad Sci USA
– volume: 64
  start-page: 844
  year: 2004
  end-page: 56
  article-title: Tissue‐wide expression profiling using cDNA subtraction and macroarrays to identify tumor‐specific genes
  publication-title: Cancer Res
– volume: 162
  start-page: 925
  year: 2003
  end-page: 32
  article-title: Gene expression patterns in renal cell carcinoma assessed by complementary DNA macroarray
  publication-title: Am J Pathol
– volume: 9
  start-page: 4641
  year: 2003
  end-page: 52
  article-title: Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia‐induced pathway
  publication-title: Clin Cancer Res
– volume: 183
  start-page: 131
  year: 1997
  end-page: 3
  article-title: The Heidelberg classification of renal cell tumours
  publication-title: J Pathol
– year: 2002
– volume: 13
  start-page: 757
  year: 1996
  end-page: 65
  article-title: Cooperation of TGF alpha and c‐Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis
  publication-title: Oncogene
– volume: 68
  start-page: 2667
  year: 2005
  end-page: 79
  article-title: Transcriptional analysis of the molecular basis of human kidney aging using cDNA macroarray profiling
  publication-title: Kidney Int
– volume: 82
  start-page: 6980
  year: 1985
  end-page: 4
  article-title: Translocation of c‐myc in the hereditary renal cell carcinoma associated with a t (3;8) (p14.2; q24.13) chromosomal translocation
  publication-title: Proc Natl Acad Sci USA
– volume: 98
  start-page: 9754
  year: 2001
  end-page: 9
  article-title: Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification
  publication-title: Proc Natl Acad Sci USA
– volume: 71
  start-page: 371
  year: 1995
  end-page: 5
  article-title: EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary Group
  publication-title: Br J Cancer
– volume: 7
  start-page: 85
  year: 1994
  end-page: 90
  article-title: Mutations of the VHL tumour suppressor gene in renal carcinoma
  publication-title: Nat Genet
– volume: 11
  start-page: 1861
  year: 2001
  end-page: 70
  article-title: Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500‐element cDNA array
  publication-title: Genome Res
– volume: 98
  start-page: 5116
  year: 2001
  end-page: 21
  article-title: Significance analysis of macroarrays applied to the ionizing radiation response
  publication-title: Proc Natl Acad Sci USA
– volume: 140
  start-page: 596
  year: 1988
  end-page: 7
  article-title: Spontaneous regression of liver metastasis from renal carcinoma
  publication-title: J Urol
– volume: 1
  start-page: 913
  year: 1995
  end-page: 20
  article-title: Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis
  publication-title: Clin Cancer Res
– volume: 154
  start-page: 981
  year: 1999
  end-page: 6
  article-title: High‐throughput tissue macroarray analysis to evaluate genes uncovered by cDNA macroarray screening in renal cell carcinoma
  publication-title: Am J Pathol
– volume: 7
  start-page: 544
  year: 1994
  end-page: 8
  article-title: The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma
  publication-title: Mod Pathol
– volume: 77
  start-page: 505
  year: 1999
  end-page: 10
  article-title: Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: an study on 29 tumors
  publication-title: J Mol Med
– volume: 346
  start-page: 1937
  year: 2002
  end-page: 47
  article-title: The use of molecular profiling to predict survival after chemotherapy for diffuse large‐B‐cell lymphoma
  publication-title: N Engl J Med
– volume: 22
  start-page: 42
  year: 1995
  end-page: 60
  article-title: Chemotherapy for advanced renal‐cell carcinoma: 1983–1993
  publication-title: Semin Oncol
– volume: 22
  start-page: 42
  year: 1995
  ident: e_1_2_7_12_2
  article-title: Chemotherapy for advanced renal‐cell carcinoma: 1983–1993
  publication-title: Semin Oncol
  contributor:
    fullname: Yagoda A
– ident: e_1_2_7_29_2
  doi: 10.1101/gr.184501
– ident: e_1_2_7_22_2
  doi: 10.1073/pnas.82.20.6980
– volume: 7
  start-page: 544
  year: 1994
  ident: e_1_2_7_20_2
  article-title: The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma
  publication-title: Mod Pathol
  contributor:
    fullname: Lager DJ
– ident: e_1_2_7_11_2
  doi: 10.1016/S0022-5347(17)41730-7
– ident: e_1_2_7_3_2
  doi: 10.1073/pnas.241500798
– ident: e_1_2_7_4_2
  doi: 10.1016/S0140-6736(02)08270-3
– ident: e_1_2_7_5_2
  doi: 10.1038/sj.onc.1207979
– ident: e_1_2_7_6_2
  doi: 10.1016/S0002-9440(10)63887-4
– ident: e_1_2_7_8_2
  doi: 10.1056/NEJMoa012914
– ident: e_1_2_7_16_2
  doi: 10.1073/pnas.091062498
– volume: 13
  start-page: 757
  year: 1996
  ident: e_1_2_7_26_2
  article-title: Cooperation of TGF alpha and c‐Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis
  publication-title: Oncogene
  contributor:
    fullname: Amundadottir LT
– ident: e_1_2_7_13_2
  doi: 10.1038/bjc.1995.75
– ident: e_1_2_7_28_2
  doi: 10.1073/pnas.171209998
– ident: e_1_2_7_7_2
  doi: 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G
– volume: 48
  start-page: 6753
  year: 1988
  ident: e_1_2_7_23_2
  article-title: Enhanced expression of c‐myc and epidermal growth factor receptor (C‐erbB‐1) genes in primary human renal cancer
  publication-title: Cancer Res
  contributor:
    fullname: Yao M
– ident: e_1_2_7_10_2
  doi: 10.1186/1471-2407-3-31
– volume: 1
  start-page: 913
  year: 1995
  ident: e_1_2_7_21_2
  article-title: Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis
  publication-title: Clin Cancer Res
  contributor:
    fullname: Uhlman DL
– ident: e_1_2_7_25_2
  doi: 10.1016/S0002-9440(10)64120-X
– ident: e_1_2_7_18_2
  doi: 10.1007/s001099900022
– ident: e_1_2_7_24_2
  doi: 10.1016/S0002-9440(10)65349-7
– ident: e_1_2_7_31_2
  doi: 10.1158/0008-5472.CAN-03-2361
– ident: e_1_2_7_9_2
  doi: 10.1038/sj.onc.1206869
– ident: e_1_2_7_2_2
  doi: 10.1038/35000501
– ident: e_1_2_7_17_2
  doi: 10.1038/ng0594-85
– start-page: 449
  volume-title: Statistical Methods
  year: 1950
  ident: e_1_2_7_15_2
  contributor:
    fullname: Bliss CI.
– ident: e_1_2_7_19_2
  doi: 10.1006/bbrc.1999.0465
– volume-title: Cancer staging manual
  year: 2002
  ident: e_1_2_7_14_2
  contributor:
    fullname: American Joint Committee on Cancer
– ident: e_1_2_7_30_2
  doi: 10.1073/pnas.1131754100
– ident: e_1_2_7_32_2
  doi: 10.1111/j.1523-1755.2005.00738.x
– volume: 9
  start-page: 4641
  year: 2003
  ident: e_1_2_7_27_2
  article-title: Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia‐induced pathway
  publication-title: Clin Cancer Res
  contributor:
    fullname: Pantuck AJ
SSID ssj0014665
Score 1.8824527
Snippet OBJECTIVES To examine differences in gene expression levels between renal cell carcinoma (RCC) tissue and ‘normal’ appearing renal tissue using a commercially...
To examine differences in gene expression levels between renal cell carcinoma (RCC) tissue and 'normal' appearing renal tissue using a commercially available...
OBJECTIVES: To examine differences in gene expression levels between renal cell carcinoma (RCC) tissue and 'normal' appearing renal tissue using a commercially...
OBJECTIVETo examine differences in gene expression levels between renal cell carcinoma (RCC) tissue and 'normal' appearing renal tissue using a commercially...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 205
SubjectTerms Biological and medical sciences
Carcinoma, Renal Cell - genetics
DNA macroarray
DNA, Neoplasm - analysis
DNA, Neoplasm - genetics
Female
gene expression
Gene Expression Profiling - methods
genomics
Humans
Kidney Neoplasms - genetics
Kidneys
macroarray
Male
Medical sciences
Middle Aged
Nephrology. Urinary tract diseases
Oligonucleotide Array Sequence Analysis
quantitative real‐time PCR
renal cell carcinoma
Tumors of the urinary system
Title Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-410X.2006.06209.x
https://www.ncbi.nlm.nih.gov/pubmed/16831170
https://search.proquest.com/docview/20077993
https://search.proquest.com/docview/68629067
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEB7Egwji-1Efaw5eu2zb9OVtfSGiHsSFvZUkTS5iu-wDVn-9M013pcsKIt4ayIRmJpP5JpnMAFxIbbhJIu4GuVQuj6VxUczCDZVnOomUeWCqaIvn6L7HH_phv45_orcwNj_E_MCNNKPar0nBhRwtKjl3udfp13cKkd9J24QnKa8e4aOXeSYp7FpVlbQkCNubQT1LB2pYqo2BGCHTjK12sQyONtFtZZ7utuBtNjEblfLWnoxlW30u5Hz8n5lvw2aNYlnXLrsdWNHFLqw91ff0e_BI2ayZntZRtgWzpcHRTLLSsKEmYroyYIpKGRXlu7hkgt08d9m7QG6I4VB8MFHnS9mH3t3t6_W9W9dtcBU6M6mb5lp2AhQ5YsVA5SGFZQWc557yJVd57Pki9kWKDS9PY0MoRit0iNPINzlXfnAAq0VZ6CNgXERhaCTuGgpdmSBNEoMI0qAPqtEvTYQD3kxG2cCm58gabg3PiE1UbDPKKjZlUwdaDWF-E-LmlaBJd-B8Jt0MlY3YIQpdTkY0TBwjovu5Bz24SREBOHBol8X36FESUJkfB6JKuL_-3-zqoUdfx38lPIF1e3BEQcansDoeTvQZQqmxbFVK8gXijg41
link.rule.ids 315,786,790,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEB5EQQXx_ajPHLx22bbpy9v6YtV1D-LC3kqSJhe1K-suqL_emabrUlEQ8dZCJrQzmeSbZDIfwLHUhpsk4m6QS-XyWBoXzSzcUHmmmUiZB6bMtuhG7R6_7of9ig6I7sLY-hCfG27kGeV8TQ5OG9JfvZy73Gv2q0OFyG-mDQSUc-j9YRlf3X3WksK2Ja-klUHgXk_r-ban2lq19CxeUG3G8l18B0jr-LZcoC5X4HHyazYv5aExHsmGev9S9fGf_n0Vlisgy1p25K3BjC7WYf62OqrfgA4VtGb6tUq0LZhlB8eVkg0MG2oSplMDpojNqBg8iRMm2Hm3xZ4EqkMMh-KNiapkyib0Li_uz9puRd3gKoxnUjfNtWwGaHWEi4HKQ8rMCjjPPeVLrvLY80XsixRfvDyNDQEZrTAmTiPf5Fz5wRbMFoNC7wDjIgpDI3HiUBjNBGmSGASRBsNQjaFpIhzwJkbKnm2FjqwW2fCM1ER8m1FWqil7deCwZs2pIM5fCa7qDhxNzJuhv5E6RKEH4xfqJo4R1P3cgu7cpAgCHNi242Lae5QExPTjQFRa99ffm51e9-hp96-CR7DQvr_tZJ2r7s0eLNp9JMo53ofZ0XCsDxBZjeRh6TEf63gSVw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swED9KB2Uwunaf7tZWD3t1iC1ZtvuWLQ1d14UxFsib0edLqRPSBNr-9b2znBaHDkbZmwU6Yd3pdL-TTncAX7TzwhdSxNxqE4tc-xjFrOLMJL5faG25b6ItxvJsIs6n2bSNf6K3MCE_xMOBG2lGs1-Tgs-t31RyEYukP23vFGTaL3uIJ18IyVNa4cPfD6mksG9TVjLQIG7vRvU8OVLHVL2aq2vkmg_lLp7Co11429in0Wu4XM8shKVc9lZL3TN3G0kf_8_U92C3hbFsENbdPmy5-g3s_Gwv6t_CBaWzZu6mDbOtWagNjnaSzTxbOCKmOwNmqJZRPbtSJ0yx4XjArhRyQy0W6papNmHKO5iMTv98O4vbwg2xQW-mjEvrdJ-jzBEscmMzisviQtjEpFoYmyepylNVYiOxZe4JxjiDHnEpU2-FSfl72K5ntfsITCiZZV7jtmHQl-FlUXiEkB6dUIeOaaEiSNYyquYhP0fV8WtERWyiapuyathU3URw1BHmIyHuXgXa9AiO19KtUNuIHap2s9U1DZPnCOn-3oNe3JQIASL4EJbF4-iy4FTnJwLZCPef_7f6ej6hr4PnEh7Dzq_hqLr4Pv7xCV6GQyQKOP4M28vFyh0irFrqo0Zf7gGR-xEG
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gene+expression+profiling+of+renal+cell+carcinoma%3A+a+DNA+macroarray+analysis&rft.jtitle=BJU+international&rft.au=LOVISOLO%2C+JON+A.J.&rft.au=CASATI%2C+BARBARA&rft.au=CLERICI%2C+LIBERO&rft.au=MARAFANTE%2C+ERMINIO&rft.date=2006-07-01&rft.issn=1464-4096&rft.eissn=1464-410X&rft.volume=98&rft.issue=1&rft.spage=205&rft.epage=216&rft_id=info:doi/10.1111%2Fj.1464-410X.2006.06209.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1464_410X_2006_06209_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon